Novartis and the Massachusetts Institute of Technology (MIT) have entered a 10-year research collaboration with the goal of transforming the pharmaceutical production process. The partnership, known as the Novartis-MIT Center for Continuous Manufacturing, will work to develop new technologies to replace the conventional batch-based system, which often includes many interruptions and work at separate sites, with continuous manufacturing processes from start to finish. The partnership combines ...